nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A11—Methotrexate—bone cancer	0.298	0.34	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—bone cancer	0.284	0.324	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—bone cancer	0.174	0.198	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—bone cancer	0.121	0.138	CbGbCtD
Cefotaxime—Nephropathy toxic—Cisplatin—bone cancer	0.00426	0.0348	CcSEcCtD
Cefotaxime—Injection site inflammation—Epirubicin—bone cancer	0.00377	0.0307	CcSEcCtD
Cefotaxime—Injection site inflammation—Doxorubicin—bone cancer	0.00348	0.0284	CcSEcCtD
Cefotaxime—Bullous eruption—Epirubicin—bone cancer	0.00318	0.0259	CcSEcCtD
Cefotaxime—Bullous eruption—Doxorubicin—bone cancer	0.00294	0.024	CcSEcCtD
Cefotaxime—Liver injury—Cisplatin—bone cancer	0.00291	0.0237	CcSEcCtD
Cefotaxime—Tenderness—Cisplatin—bone cancer	0.00281	0.0229	CcSEcCtD
Cefotaxime—Pain—Carboplatin—bone cancer	0.00255	0.0208	CcSEcCtD
Cefotaxime—Body temperature increased—Carboplatin—bone cancer	0.00235	0.0192	CcSEcCtD
Cefotaxime—Local reaction—Epirubicin—bone cancer	0.00227	0.0185	CcSEcCtD
Cefotaxime—Local reaction—Doxorubicin—bone cancer	0.0021	0.0171	CcSEcCtD
Cefotaxime—Encephalopathy—Methotrexate—bone cancer	0.00209	0.0171	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Cisplatin—bone cancer	0.00197	0.0161	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—bone cancer	0.00149	0.0122	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—bone cancer	0.00138	0.0113	CcSEcCtD
Cefotaxime—Renal failure—Cisplatin—bone cancer	0.00135	0.011	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—bone cancer	0.00134	0.011	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—bone cancer	0.00127	0.0103	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—bone cancer	0.00126	0.0103	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—bone cancer	0.00126	0.0103	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—bone cancer	0.00121	0.00984	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—bone cancer	0.0012	0.00979	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—bone cancer	0.00119	0.00968	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—bone cancer	0.00118	0.00963	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—bone cancer	0.00116	0.00949	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—bone cancer	0.00112	0.00911	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—bone cancer	0.00111	0.00906	CcSEcCtD
Cefotaxime—Arrhythmia—Cisplatin—bone cancer	0.0011	0.00896	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—bone cancer	0.0011	0.00896	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—bone cancer	0.00109	0.00891	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—bone cancer	0.00104	0.00852	CcSEcCtD
Cefotaxime—Ill-defined disorder—Cisplatin—bone cancer	0.000993	0.0081	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—bone cancer	0.000966	0.00788	CcSEcCtD
Cefotaxime—Malaise—Cisplatin—bone cancer	0.000965	0.00787	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—bone cancer	0.000959	0.00782	CcSEcCtD
Cefotaxime—Leukopenia—Cisplatin—bone cancer	0.000958	0.00781	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—bone cancer	0.000955	0.00779	CcSEcCtD
Cefotaxime—Convulsion—Cisplatin—bone cancer	0.000927	0.00756	CcSEcCtD
Cefotaxime—Discomfort—Cisplatin—bone cancer	0.0009	0.00734	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—bone cancer	0.000887	0.00724	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—bone cancer	0.000883	0.00721	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000878	0.00716	CcSEcCtD
Cefotaxime—Anaphylactic shock—Cisplatin—bone cancer	0.000873	0.00712	CcSEcCtD
Cefotaxime—Thrombocytopenia—Cisplatin—bone cancer	0.000855	0.00697	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—bone cancer	0.000834	0.00681	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000822	0.0067	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—bone cancer	0.000788	0.00643	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—bone cancer	0.000781	0.00637	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00076	0.0062	CcSEcCtD
Cefotaxime—Pain—Cisplatin—bone cancer	0.000747	0.00609	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000745	0.00608	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—bone cancer	0.000738	0.00602	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—bone cancer	0.000737	0.00602	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—bone cancer	0.000722	0.00589	CcSEcCtD
Cefotaxime—Feeling abnormal—Cisplatin—bone cancer	0.00072	0.00587	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—bone cancer	0.000701	0.00572	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000697	0.00569	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—bone cancer	0.000691	0.00564	CcSEcCtD
Cefotaxime—Body temperature increased—Cisplatin—bone cancer	0.00069	0.00563	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—bone cancer	0.000685	0.00559	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—bone cancer	0.000682	0.00557	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—bone cancer	0.000678	0.00553	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—bone cancer	0.000674	0.0055	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—bone cancer	0.000674	0.0055	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—bone cancer	0.000656	0.00535	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000645	0.00526	CcSEcCtD
Cefotaxime—Hypersensitivity—Cisplatin—bone cancer	0.000643	0.00525	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—bone cancer	0.000639	0.00522	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—bone cancer	0.000638	0.0052	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—bone cancer	0.000634	0.00518	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—bone cancer	0.000634	0.00517	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—bone cancer	0.000631	0.00515	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—bone cancer	0.000631	0.00515	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—bone cancer	0.000607	0.00495	CcSEcCtD
Cefotaxime—Diarrhoea—Cisplatin—bone cancer	0.000597	0.00487	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—bone cancer	0.000597	0.00487	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—bone cancer	0.000587	0.00479	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—bone cancer	0.000584	0.00476	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—bone cancer	0.000584	0.00476	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—bone cancer	0.000564	0.0046	CcSEcCtD
Cefotaxime—Vomiting—Cisplatin—bone cancer	0.000555	0.00453	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—bone cancer	0.000552	0.0045	CcSEcCtD
Cefotaxime—Rash—Cisplatin—bone cancer	0.000551	0.00449	CcSEcCtD
Cefotaxime—Dermatitis—Cisplatin—bone cancer	0.00055	0.00449	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—bone cancer	0.000545	0.00444	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—bone cancer	0.000529	0.00432	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—bone cancer	0.000526	0.00429	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—bone cancer	0.000522	0.00426	CcSEcCtD
Cefotaxime—Nausea—Cisplatin—bone cancer	0.000519	0.00423	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—bone cancer	0.00051	0.00416	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—bone cancer	0.000509	0.00415	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—bone cancer	0.000495	0.00404	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—bone cancer	0.000494	0.00403	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—bone cancer	0.000492	0.00401	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—bone cancer	0.000479	0.00391	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—bone cancer	0.000476	0.00388	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—bone cancer	0.000472	0.00385	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—bone cancer	0.000469	0.00383	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—bone cancer	0.000462	0.00377	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—bone cancer	0.000458	0.00374	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—bone cancer	0.000455	0.00371	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—bone cancer	0.000448	0.00366	CcSEcCtD
Cefotaxime—Shock—Epirubicin—bone cancer	0.000441	0.0036	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—bone cancer	0.00044	0.00359	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—bone cancer	0.000439	0.00358	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—bone cancer	0.000428	0.00349	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—bone cancer	0.000415	0.00338	CcSEcCtD
Cefotaxime—Pain—Methotrexate—bone cancer	0.00041	0.00334	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—bone cancer	0.000408	0.00333	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—bone cancer	0.000406	0.00331	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—bone cancer	0.000395	0.00322	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—bone cancer	0.000392	0.0032	CcSEcCtD
Cefotaxime—Pain—Epirubicin—bone cancer	0.000383	0.00313	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—bone cancer	0.000381	0.00311	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—bone cancer	0.000379	0.00309	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—bone cancer	0.000379	0.00309	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—bone cancer	0.00037	0.00301	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—bone cancer	0.000367	0.00299	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—bone cancer	0.000356	0.00291	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—bone cancer	0.000355	0.00289	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—bone cancer	0.000354	0.00289	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—bone cancer	0.000354	0.00289	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—bone cancer	0.000353	0.00288	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—bone cancer	0.000342	0.00279	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—bone cancer	0.000339	0.00277	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—bone cancer	0.000339	0.00277	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—bone cancer	0.00033	0.0027	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—bone cancer	0.00033	0.00269	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—bone cancer	0.000328	0.00268	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—bone cancer	0.000328	0.00268	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—bone cancer	0.000328	0.00267	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—bone cancer	0.000317	0.00259	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—bone cancer	0.000307	0.0025	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—bone cancer	0.000306	0.00249	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—bone cancer	0.000305	0.00249	CcSEcCtD
Cefotaxime—Rash—Methotrexate—bone cancer	0.000302	0.00246	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—bone cancer	0.000302	0.00246	CcSEcCtD
Cefotaxime—Headache—Methotrexate—bone cancer	0.0003	0.00245	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—bone cancer	0.000294	0.00239	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—bone cancer	0.000285	0.00233	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—bone cancer	0.000285	0.00232	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—bone cancer	0.000284	0.00232	CcSEcCtD
Cefotaxime—Rash—Epirubicin—bone cancer	0.000283	0.00231	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—bone cancer	0.000282	0.0023	CcSEcCtD
Cefotaxime—Headache—Epirubicin—bone cancer	0.000281	0.00229	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—bone cancer	0.000266	0.00217	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—bone cancer	0.000264	0.00215	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—bone cancer	0.000262	0.00213	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—bone cancer	0.000261	0.00213	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—bone cancer	0.00026	0.00212	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—bone cancer	0.000246	0.00201	CcSEcCtD
